Beneficient (BENF) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Achieved a second consecutive quarter of positive GAAP net income, with Q2 FY2025 net income of $9.7 million, reversing a $381.8 million loss in Q2 FY2024, driven by investment gains and liability resolution.
Strengthened balance sheet by redesignating $125.5 million of preferred equity as non-redeemable, significantly improving the permanent equity deficit.
Expanded product offerings, entered adjacent markets, and streamlined cost structure for greater efficiency and scalability.
Board authorized up to $5 billion in fiduciary financings to Customer ExAlt Trusts, supporting future growth.
Significant reduction in stock overhang as a major shareholder liquidated over 90% of its position, broadening the shareholder base.
Financial highlights
Revenues rose to $8.6 million in Q2 FY2025 from $(42.8) million in Q2 FY2024; year-to-date revenues reached $18.6 million.
Operating expenses dropped to $22.3 million in Q2 FY2025 (including $0.3 million goodwill impairment) from $339.0 million in Q2 FY2024 (including $306.7 million impairment); excluding non-cash items, Q2 FY2025 operating expenses declined 31.9% year-over-year.
GAAP net income was $9.7 million for the quarter and $54.1 million year-to-date; basic EPS of $2.98 for Q2 and $14.58 year-to-date.
Cash and cash equivalents stood at $4.5 million at quarter-end; total debt was $124.1 million.
Investments at fair value increased to $335.0 million as of September 30, 2024, from $329.1 million at prior fiscal year-end.
Outlook and guidance
Management expects the platform to support substantial growth as new opportunities are identified and negotiated in private investment markets.
Expectation of increased deal closings in the next quarter following shareholder approval to increase authorized shares.
Anticipate further development and rollout of MAPS platform functionality into 2025.
Management expects the need for additional capital within the next twelve months, likely through debt or equity issuance, including the SEPA facility.
Industry participants forecast improved liquidity and deal activity over the next 12-24 months, with optimism for a more robust IPO and M&A market.
Latest events from Beneficient
- Convertible preferred shares fund a $7.44M commitment, with strict transfer and conversion limits.BENF
Registration filing29 Jul 2026 - Closed $7.44M AI fund transaction, boosting book value; stockholder approval needed for share conversion.BENF
Proxy filing13 Jul 2026 - Litigation resolved, expenses reduced, and new business lines launched amid ongoing losses.BENF
Q4 202629 Jun 2026 - $8.75M capital deal adds $9.77M in value, pending shareholder approval for stock conversion.BENF
Proxy filing10 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and an expanded incentive plan.BENF
Proxy Filing13 Mar 2026 - Net income of $19.9M and Nasdaq compliance achieved, but legal and liquidity risks remain.BENF
Q3 202617 Feb 2026 - Achieved first profitable quarter and leads with a fintech platform for alternative asset liquidity.BENF
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - First profitable quarter, revenue up, costs down 70%, and legal risks resolved.BENF
Q1 20252 Feb 2026 - Nine-month EPS up, Q3 loss narrows, equity improves, digital asset expansion planned.BENF
Q3 202524 Dec 2025